BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 11430636)

  • 41. Single and multiple dose pharmacokinetic evaluation of a transdermal delivery system of imipramine hydrochloride.
    Panchagnula R; Dravid P; Jain A; Khandavilli S
    Arzneimittelforschung; 2005; 55(4):198-204. PubMed ID: 15901042
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Imipramine and desipramine disposition in the elderly.
    Abernethy DR; Greenblatt DJ; Shader RI
    J Pharmacol Exp Ther; 1985 Jan; 232(1):183-8. PubMed ID: 3965690
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pharmacokinetic and pharmacodynamic studies of drug interaction following oral administration of imipramine and sodium alginate in rats.
    Watanabe S; Suemaru K; Inoue N; Imai K; Aimoto T; Araki H
    Naunyn Schmiedebergs Arch Pharmacol; 2008 Jul; 378(1):85-91. PubMed ID: 18449531
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparison of verapamil, diltiazem, and labetalol on the bioavailability and metabolism of imipramine.
    Hermann DJ; Krol TF; Dukes GE; Hussey EK; Danis M; Han YH; Powell JR; Hak LJ
    J Clin Pharmacol; 1992 Feb; 32(2):176-83. PubMed ID: 1613128
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Imipramine pharmacokinetics in depressed geriatric patients.
    Benetello P; Furlanut M; Zara G; Baraldo M
    Int J Clin Pharmacol Res; 1990; 10(3):191-5. PubMed ID: 2228344
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Quantification and mechanism of the fluoxetine and tricyclic antidepressant interaction.
    Bergstrom RF; Peyton AL; Lemberger L
    Clin Pharmacol Ther; 1992 Mar; 51(3):239-48. PubMed ID: 1544284
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Simultaneous determination of imipramine and its metabolite desipramine in human plasma by capillary gas chromatography with mass-selective detection.
    Pommier F; Sioufi A; Godbillon J
    J Chromatogr B Biomed Sci Appl; 1997 Dec; 703(1-2):147-58. PubMed ID: 9448071
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inhibition of P-glycoprotein enhances transport of imipramine across the blood-brain barrier: microdialysis studies in conscious freely moving rats.
    O'Brien FE; Clarke G; Fitzgerald P; Dinan TG; Griffin BT; Cryan JF
    Br J Pharmacol; 2012 Jun; 166(4):1333-43. PubMed ID: 22250926
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of venlafaxine on imipramine metabolism.
    Albers LJ; Reist C; Vu RL; Fujimoto K; Ozdemir V; Helmeste D; Poland R; Tang SW
    Psychiatry Res; 2000 Nov; 96(3):235-43. PubMed ID: 11084219
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Inhibition of imipramine N-demethylation by fluvoxamine in Chinese young men.
    Xu ZH; Huang SL; Zhou HH
    Zhongguo Yao Li Xue Bao; 1996 Sep; 17(5):399-402. PubMed ID: 9863158
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Excess fatality from desipramine and dosage recommendations.
    Amitai Y; Frischer H
    Ther Drug Monit; 2004 Oct; 26(5):468-73. PubMed ID: 15385827
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Vinpocetine therapy does not change imipramine pharmacokinetics in man.
    Hitzenberger G; Schmid R; Braun W; Grandt R
    Int J Clin Pharmacol Ther Toxicol; 1990 Mar; 28(3):99-104. PubMed ID: 2318551
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Percutaneous absorption of tricyclic antidepressants: amitriptyline, nortriptyline, imipramine, and desipramine.
    Bailey DN
    J Anal Toxicol; 1990; 14(4):217-8. PubMed ID: 2395341
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Fluoxetine-imipramine interaction.
    Leroi I; Walentynowicz MA
    Can J Psychiatry; 1996 Jun; 41(5):318-9. PubMed ID: 8793156
    [No Abstract]   [Full Text] [Related]  

  • 55. Citalopram: interaction studies with levomepromazine, imipramine, and lithium.
    Gram LF; Hansen MG; Sindrup SH; Brøsen K; Poulsen JH; Aaes-Jørgensen T; Overø KF
    Ther Drug Monit; 1993 Feb; 15(1):18-24. PubMed ID: 8451775
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Death of two subjects due to imipramine and desipramine metabolite accumulation during chronic therapy: a review of the literature and possible mechanisms.
    Swanson JR; Jones GR; Krasselt W; Denmark LN; Ratti F
    J Forensic Sci; 1997 Mar; 42(2):335-9. PubMed ID: 9068197
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pharmacokinetics of mirtazapine from orally administered tablets: influence of a high-fat meal.
    Cohen M; Panagides J; Timmer CJ; Huisman JA
    Eur J Drug Metab Pharmacokinet; 1997; 22(2):103-10. PubMed ID: 9248777
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The distribution of imipramine and desipramine in rat brain regions after single and chronic administration of imipramine.
    Szymura-Oleksiak J; Panas M; Chruściel W
    Pol J Pharmacol Pharm; 1984; 36(1):21-6. PubMed ID: 6462958
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Plasma levels of imipramine and desipramine in man after different routes of administration.
    Nagy A; Johansson R
    Naunyn Schmiedebergs Arch Pharmacol; 1975; 290(2-3):145-60. PubMed ID: 1102994
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pharmacokinetics of desipramine HCl when administered with cinacalcet HCl.
    Harris RZ; Salfi M; Posvar E; Hoelscher D; Padhi D
    Eur J Clin Pharmacol; 2007 Feb; 63(2):159-63. PubMed ID: 16680561
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.